| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID | 
|---|---|---|---|---|---|---|---|---|
| TVIS10036226 | HBV | ENSG00000170190.16 | protein_coding | SLC16A5 | No | No | 9121 | O15375 | 
| TVIS30077467 | HIV | ENSG00000170190.16 | protein_coding | SLC16A5 | No | No | 9121 | O15375 | 
| TVIS30077647 | HIV | ENSG00000170190.16 | protein_coding | SLC16A5 | No | No | 9121 | O15375 | 
| TVIS20053172 | HPV | ENSG00000170190.16 | protein_coding | SLC16A5 | No | No | 9121 | O15375 | 
| TVIS44018058 | HTLV-1 | ENSG00000170190.16 | protein_coding | SLC16A5 | No | No | 9121 | O15375 | 
    Target Gene Table
    ▼
    TCGA Plot Options
    ▼
    Drug Information
    ▼
| Gene | SLC16A5 | 
|---|---|
| DrugBank ID | DB00119 | 
| Drug Name | Pyruvic acid | 
| Target ID | BE0000386 | 
| UniProt ID | O15375 | 
| Regulation Type | |
| PubMed IDs | 16604139 | 
| Citations | Bonen A, Heynen M, Hatta H: Distribution of monocarboxylate transporters MCT1-MCT8 in rat tissues and human skeletal muscle. Appl Physiol Nutr Metab. 2006 Feb;31(1):31-9. | 
| Groups | Approved; Investigational; Nutraceutical | 
| Direct Classification | Alpha-keto acids and derivatives | 
| SMILES | CC(=O)C(O)=O | 
| Pathways | Citrullinemia Type I; 4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency; Glycogenosis, Type IB; Argininemia; Pyruvate Kinase Deficiency; Pyruvate Carboxylase Deficiency; Amino Sugar Metabolism; The Oncogenic Action of Fumarate; 3-Phosphoglycerate Dehydrogenase Deficiency; Glycolysis; Non-Ketotic Hyperglycinemia; 2-Hydroxyglutric Aciduria (D and L Form); Glucose-Alanine Cycle; G(M2)-Gangliosidosis: Variant B, Tay-Sachs Disease; Alanine Metabolism; Hyperglycinemia, Non-Ketotic; Cystinosis, Ocular Nonnephropathic; Dimethylglycine Dehydrogenase Deficiency; Glycogenosis, Type VII. Tarui Disease; Dihydropyrimidine Dehydrogenase Deficiency (DHPD); Lactic Acidemia; Homocarnosinosis; Primary Hyperoxaluria Type I; Ornithine Transcarbamylase Deficiency (OTC Deficiency); The Oncogenic Action of L-2-Hydroxyglutarate in Hydroxygluaricaciduria; Sarcosinemia; Urea Cycle; Phosphoenolpyruvate Carboxykinase Deficiency 1 (PEPCK1); Cysteine Metabolism | 
| PharmGKB | PA164778686 | 
| ChEMBL | CHEMBL1162144 |